CIK 0001370053 · Non-accelerated filer<br>Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203828755
- Phone
- 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-16 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +5,000 | $14.02 | $70K | 13,520 |
| 2024-09-16 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale 10b5-1 | −6,500 | $40.13 | $261K | 7,020 |
| 2024-09-16 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,000 | 73,000 | ||
| 2024-09-16 | Lizzul Paul F. Chief Medical Officer | Sale 10b5-1 | −2,220 | $38.93 | $86K | 15,398 |
| 2024-09-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,220 | $38.93 | $86K | 4,744 |
| 2024-09-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +10,000 | $20.16 | $202K | 14,744 |
| 2024-09-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −10,000 | $40.13 | $401K | 4,744 |
| 2024-09-16 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −10,000 | 80,600 | ||
| 2024-09-15 | Orwin John A Director | Option exercise | +1,300 | 3,335 | ||
| 2024-09-15 | Orwin John A Director | Option exercise · Restricted Stock Unit | −1,300 | 2,600 | ||
| 2024-09-14 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +6,000 | 10,740 | ||
| 2024-09-14 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −6,000 | 0 | ||
| 2024-09-14 | Lizzul Paul F. Chief Medical Officer | Option exercise 10b5-1 | +6,000 | 17,618 | ||
| 2024-09-14 | Lizzul Paul F. Chief Medical Officer | Option exercise · Restricted Stock Unit 10b5-1 | −6,000 | 0 | ||
| 2024-09-14 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +6,000 | 6,964 | ||
| 2024-09-14 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit 10b5-1 | −6,000 | 0 | ||
| 2024-08-14 | Lizzul Paul F. Chief Medical Officer | Option exercise 10b5-1 | +2,000 | $18.50 | $37K | 13,618 |
| 2024-08-14 | Lizzul Paul F. Chief Medical Officer | Sale 10b5-1 | −2,000 | $40.00 | $80K | 11,618 |
| 2024-08-14 | Lizzul Paul F. Chief Medical Officer | Option exercise · Common 10b5-1 | −2,000 | 86,500 | ||
| 2024-08-14 | EcoR1 Capital, LLC 10% owner | Purchase | +273,972 | $36.50 | $10.0M | 7,794,996 |
Page 15 of 17 · 339 trades